These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 24357220)

  • 1. Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.
    Allison GM; Muldoon EG; Kent DM; Paulus JK; Ruthazer R; Ren A; Snydman DR
    Clin Infect Dis; 2014 Mar; 58(6):812-9. PubMed ID: 24357220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.
    Durojaiye OC; Kritsotakis EI; Johnston P; Kenny T; Ntziora F; Cartwright K
    Clin Microbiol Infect; 2019 Jul; 25(7):905.e1-905.e7. PubMed ID: 30502491
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factors for readmission in patients discharged with outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Huang V; Ruhe JJ; Lerner P; Fedorenko M
    BMC Pharmacol Toxicol; 2018 Aug; 19(1):50. PubMed ID: 30081959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.
    Briquet C; Cornu O; Servais V; Blasson C; Vandeleene B; Yildiz H; Stainier A; Yombi JC
    Acta Clin Belg; 2020 Aug; 75(4):275-283. PubMed ID: 31023169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic Foot Infection and Select Comorbidities Drive Readmissions in Outpatient Parenteral Antimicrobial Therapy.
    Barnes A; Nunez M
    Am J Med Sci; 2021 Feb; 361(2):233-237. PubMed ID: 33097196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates.
    Mansour O; Heslin J; Townsend JL
    J Antimicrob Chemother; 2018 Nov; 73(11):3181-3188. PubMed ID: 30085088
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).
    Drew R; Brenneman E; Funaro J; Lee HJ; Yarrington M; Dicks K; Gallagher D
    PLOS Digit Health; 2023 Aug; 2(8):e0000323. PubMed ID: 37531342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
    Palms DL; Jacob JT
    Clin Infect Dis; 2020 Jan; 70(1):67-74. PubMed ID: 30810165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for readmission among patients receiving outpatient parenteral antimicrobial therapy: a retrospective cohort study.
    Douiyeb S; de la Court JR; Tuinte B; Sombogaard F; Schade RP; Kuijvenhoven M; Minderhoud T; Sigaloff KCE
    Int J Clin Pharm; 2022 Apr; 44(2):557-563. PubMed ID: 35157228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of Hospital Readmission in Patients Receiving Outpatient Parenteral Antimicrobial Therapy.
    Means L; Bleasdale S; Sikka M; Gross AE
    Pharmacotherapy; 2016 Aug; 36(8):934-9. PubMed ID: 27393717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. OPAT in Switzerland: single-center experience of a model to treat complicated infections.
    Erba A; Beuret M; Daly ML; Khanna N; Osthoff M
    Infection; 2020 Apr; 48(2):231-240. PubMed ID: 31828605
    [TBL] [Abstract][Full Text] [Related]  

  • 12. External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.
    Durojaiye OC; Morgan R; Chelaghma N; Palit J; Keil C; Omer R; Cartwright K; Kritsotakis EI
    J Antimicrob Chemother; 2021 Jul; 76(8):2204-2212. PubMed ID: 33895844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Administered Outpatient Antimicrobial Infusion by Uninsured Patients Discharged from a Safety-Net Hospital: A Propensity-Score-Balanced Retrospective Cohort Study.
    Bhavan KP; Brown LS; Haley RW
    PLoS Med; 2015 Dec; 12(12):e1001922. PubMed ID: 26671467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristics, safety and cost-effectiveness analysis of self-administered outpatient parenteral antibiotic therapy via a disposable elastomeric continuous infusion pump at two county hospitals in Houston, Texas, United States.
    Karimaghaei S; Rao A; Chijioke J; Finch N; Nigo M
    J Clin Pharm Ther; 2022 Feb; 47(2):211-217. PubMed ID: 34699089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of outpatient parenteral antibiotic therapy in the treatment of community acquired skin and soft tissue infections in Singapore.
    Chan M; Ooi CK; Wong J; Zhong L; Lye D
    BMC Infect Dis; 2017 Jul; 17(1):474. PubMed ID: 28683717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.
    Huck D; Ginsberg JP; Gordon SM; Nowacki AS; Rehm SJ; Shrestha NK
    J Antimicrob Chemother; 2014 Jan; 69(1):228-33. PubMed ID: 23887864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bundle in the Bronx: Impact of a Transition-of-Care Outpatient Parenteral Antibiotic Therapy Bundle on All-Cause 30-Day Hospital Readmissions.
    Madaline T; Nori P; Mowrey W; Zukowski E; Gohil S; Sarwar U; Weston G; Urrely R; Palombelli M; Pierino VF; Parsons V; Ehrlich A; Ostrowsky B; Corpuz M; Pirofski LA
    Open Forum Infect Dis; 2017; 4(2):ofx097. PubMed ID: 28852672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of a risk assessment model in predicting 30 day unplanned hospital readmission in adult patients receiving outpatient parenteral antimicrobial therapy.
    Brenneman E; Funaro J; Dicks K; Yarrington M; Lee HJ; Erkanli A; Hung F; Drew R
    JAC Antimicrob Resist; 2023 Feb; 5(1):dlad019. PubMed ID: 36824226
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.
    Sumpter C; Russell CD; Mackintosh C
    Int J Equity Health; 2020 Sep; 19(1):150. PubMed ID: 32873291
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An outcomes analysis of outpatient parenteral antibiotic therapy (OPAT) in a large Asian cohort.
    Seetoh T; Lye DC; Cook AR; Archuleta S; Chan M; Sulaiman Z; Zhong L; Llorin RM; Balm M; Fisher D
    Int J Antimicrob Agents; 2013 Jun; 41(6):569-73. PubMed ID: 23453619
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.